RAPS.org
|
About RAPS
|
RAPS Store
|
Contact
Guest
| limited access
log in
Join RAPS
Get the Mobile App
|
RF in Your Email
News
Features
Archives
About RF
Advertise
Regulatory Exchange
Departments:
Under RAPS
Quality & Compliance
Science & Technology
Perspective
It's the Law
Focus Online
»
News
News
Search:
Latest News
|
9 July 2012
Untitled Letter to Acorda Therapeutics Highlights Recent FDA Review Trends
0 Likes
The US Food and Drug Administration (FDA) sent two untitled warning letters to pharmaceutical companies in as many days in June, warning two companies regarding alleged infractions contained within
Read More...
Tags:
Acorda
FDA
Notice of Violation
NOV
Survey
Untitled Letter
Video
Warning
Get
RF Today
RF Today
is
Regulatory Focus'
daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more.
Learn more
Sign Up
Most Viewed
Most Popular
Most Popular
Regulatory Intelligence Firm Graematter Gets Major Funding to Navigate Complex FDA Environment
22 May 2013
Interview: FDA's UDI Architect Jay Crowley on the Agency's Approach to UDI and Pending Changes
2 May 2013
Citing Personal Reasons, Major Official Announces Departure from FDA
3 May 2013
Patients First: FDA's New Website Aims to Make Regulations Clear to Everyone, Invite Involvement
23 April 2013
Senate Track and Trace Legislative Draft Includes Lot-Level Requirements and New Penalties
22 April 2013
10 Takeaways from FDA's 2013 Warning and Untitled Letters: 5 - 1
18 June 2013
Regulatory Reconnaissance (22 April 2013)
22 April 2013
Regulatory Reconnaissance (25 April 2013)
25 April 2013
Most Viewed
Public Warms to FDA in Recent Gallup Poll
28 May 2013
FDA Finalizes Changes to Orphan Drug Regulation, With Emphasis on Clarifying Existing Policies
11 June 2013
Warning Letter to Company Cites Low Supplies of Toilet Paper
15 May 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars
30 April 2013
Interview: FDA's UDI Architect Jay Crowley on the Agency's Approach to UDI and Pending Changes
2 May 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA
29 April 2013
New Legislation Seeks Creation of Provisional Approval Pathway for New Drugs
23 May 2013
New FDA Draft Guidance Aims to Clarify Compassionate Use Process
9 May 2013
